110543-98-1 Usage
Description
ETHYL5-ACETOXY-6-BROMO-2-(BROMOMETHYL)-1-METHYLINDOLE-3is a complex organic compound with a 1-methylindole core structure, featuring ethyl, acetoxy, bromo, and methyl groups attached to it. The presence of a bromomethyl group adds to its structural complexity. The combination of these chemical groups endows the compound with unique properties, which may find applications in various fields such as pharmaceuticals, agrochemicals, and materials science. Further analysis and study are required to determine its specific uses and effects.
Uses
Used in Pharmaceutical Industry:
ETHYL5-ACETOXY-6-BROMO-2-(BROMOMETHYL)-1-METHYLINDOLE-3is used as a pharmaceutical compound for its potential therapeutic properties. The specific application reason is not provided in the materials, but the compound's unique structure and properties may contribute to its use in drug development.
Used in Agrochemical Industry:
ETHYL5-ACETOXY-6-BROMO-2-(BROMOMETHYL)-1-METHYLINDOLE-3is used as an agrochemical compound for its potential applications in crop protection or enhancement. The specific application reason is not provided in the materials, but the compound's unique structure and properties may contribute to its use in developing new agrochemical products.
Used in Materials Science:
ETHYL5-ACETOXY-6-BROMO-2-(BROMOMETHYL)-1-METHYLINDOLE-3is used as a material in materials science for its potential applications in the development of new materials with unique properties. The specific application reason is not provided in the materials, but the compound's unique structure and properties may contribute to its use in creating innovative materials for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 110543-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,5,4 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 110543-98:
(8*1)+(7*1)+(6*0)+(5*5)+(4*4)+(3*3)+(2*9)+(1*8)=91
91 % 10 = 1
So 110543-98-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H15Br2NO4/c1-4-21-15(20)14-9-5-13(22-8(2)19)10(17)6-11(9)18(3)12(14)7-16/h5-6H,4,7H2,1-3H3
110543-98-1Relevant articles and documents
SYNTHESIS OF A NEW ANTIVIRAL AGENT, ARBIDOLE
Trofimov, F.A.,Tsyshkova, N.G.,Zotova, S.A.,Grinev, A.N.
, p. 75 - 76 (1993)
-
Method for synthesizing arbidol hydrochloride intermediate
-
Paragraph 0013, (2020/08/25)
The invention discloses a method for synthesizing an arbidol hydrochloride intermediate, and belongs to the technical field of medical intermediates. According to the method, 5-hydroxy-1, 2-dimethylindole-3-carboxylic acid ethyl ester is used as a raw material, and esterification, bromination, thiophenol and deprotection, Mannich reaction and salification are performed to obtain arbidol hydrochloride. In the process of generating the most important intermediate 5-acetoxy-6-bromo-2-bromomethyl-1-methylindole-3-carboxylic acid through bromination reaction, (p-methyl isopropyl benzene)-rutheniumdichloride dimer is used as a catalyst, NBS serves as a bromination reagent, DMA serves as a solvent to replace a traditional bromine bromination reagent, reaction conditions are mild, reaction selectivity is high, raw material sources are convenient, pollution of bromine to the environment can be avoided, and the catalytic activity of the novel catalyst is not reduced due to the influence of thereaction environment. Therefore, the method has the advantages of few byproducts, high yield, low production cost, high safety, energy conservation and the like, and meets the modern chemical production requirements of green reaction.
ARBIDOL ANALOGS WITH IMPROVED INFLUENZA HEMAGGLUTININ POTENCY
-
, (2018/07/05)
The invention provides a series of analogs of arbidol having enhanced binding activity with respect to influenza hemagglutinin. Accordingly, the invention can provide a method of inhibiting the bioactivity of viral hemagglutinin activity, which is an essential step in the entry of infectious viral particles into host cells. The invention also can provide a method of treatment of influence, comprising administering an effective amount of a compound of formula (A), wherein X is S or O, to a patient afflicted therewith.